The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies
Open accessAbstract
Rationale The neurotrophin hypothesis of major depressive disorder (MDD) postulates that this illness results from aberrant neurogenesis in brain regions that regulates emotion and memory. Notwithstanding this theory has primarily implicated BDNF in the neurobiology of MDD. Recent evidence suggests that other trophic factors namely GDNF, VEGF and IGF-1 may also be involved.Purpose The present review aimed to critically summarize evidence regarding changes in GDNF, IGF-1 and VEGF in individuals with MDD compared to healthy controls. In addition, we also evaluated the role of these mediators as potential treatment response biomarkers for MDD.Methods A comprehensive review of original studies studies measuring peripheral, central or mRNA levels of GDNF, IGF-1 or VEGF in patients with MDD was conducted. The PubMed/MEDLINE database was searched for peer-reviewed studies published in English through June 2nd, 2015.Results Most studies reported a reduction in peripheral GDNF and its mRNA levels in MDD patients versus controls. In contrast, IGF-1 levels in MDD patients compared to controls were discrepant across studies. Finally, most studies reported high peripheral VEGF levels and mRNA expression in MDD patients compared to healthy controls.Conclusions GDNF, IGF-1 and VEGF levels and their mRNA expression appear to be differentially altered in MDD patients compared to healthy individuals, indicating that these molecules might play an important role in the pathophysiology of depression and antidepressant action of therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It binds to the GDNF-family receptors α1 (GFRα1) activating tyrosine kinase signaling (Sharma et al. 2016).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Sharma et al. 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Decreased serum brain-derived neurotrophic factor levels in major depressed patients
Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., & Aubry, J.-M. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00005-7 · Cited by 1,232
Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication
Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F., & Young, L. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01083-6 · Cited by 1,164
Dwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.804 · Cited by 875
Karege, F., Vaudan, G., Schwald, M., Perroud, N., & La Harpe, R. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.12.020 · Cited by 600
Taliaz, D., Stall, N., Dar, D. E., & Zangen, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.67 · Cited by 454
Guilloux, J.-P., Douillard-Guilloux, G., Kota, R., Wang, X., Gardier, A. M., Martinowich, K., Tseng, G. C., Lewis, D. A., & Sibille, E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.113 · Cited by 378
Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects
Hoshaw, B. A., Malberg, J. E., & Lucki, I. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.007 · Cited by 348
Mobilization, E. (1989) · Cited by 298
Cited by
Sorted by citations
Blood-brain barrier regulation in psychiatric disorders
Kealy, J., Greene, C., & Campbell, M. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.033 · Cited by 318
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308
“It binds to the GDNF-family receptors α1 (GFRα1) activating tyrosine kinase signaling (Sharma et al. 2016).”
BackgroundAn astroglial basis of major depressive disorder? An overview
Wang, Q., Jie, W., Liu, J., Yang, J., & Gao, T. (2017) · Glia · doi:10.1002/glia.23143 · Cited by 222
Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine
Deyama, S., & Duman, R. S. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172837 · Cited by 186
Naoi, M., Maruyama, W., & Shamoto‐Nagai, M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1709-8 · Cited by 191
Walker, W. H., Borniger, J. C., Gaudier-Diaz, M. M., Hecmarie Meléndez-Fernández, O., Pascoe, J. L., Courtney DeVries, A., & Nelson, R. J. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0430-4 · Cited by 129
Biomarkers for major depressive disorder
Hacımusalar, Y., & Eşel, E. (2017) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2017.19482 · Cited by 123
Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders
Galvez-Contreras, A. Y., Campos-Ordonez, T., Lopez-Virgen, V., Gomez-Plascencia, J., Ramos-Zuniga, R., & Gonzalez-Perez, O. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.08.004 · Cited by 112
Gonçalves, R. A., Wijesekara, N., Fraser, P. E., & Felice, F. G. D. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00017 · Cited by 108
Shi, Y., Luan, D., Song, R., & Zhang, Z. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.09.633 · Cited by 105
Linalool as a Therapeutic and Medicinal Tool in Depression Treatment: A Review
dos Santos, É. R. Q., Maia, J. G. S., Fontes-Júnior, E. A., & Maia, C. D. S. F. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210920094504 · Cited by 116
Inflammatory Markers in Anorexia Nervosa: An Exploratory Study
Dalton, B., Campbell, I. C., Chung, R., Breen, G. D., Schmidt, U. H., & Himmerich, H. (2018) · Nutrients · doi:10.3390/nu10111573 · Cited by 97
Mosiołek, A., Mosiołek, J., Jakima, S., Pięta, A., & Szulc, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153377 · Cited by 87
Physical exercise, IGF-1 and cognition A systematic review of experimental studies in the elderly
Stein, A. M., da Silva, T. M. V., Coelho, F. G. D. M., Arantes, F. J., Costa, J. L. R., Teodoro, E. F., & Galduróz, J. C. F. (2018) · Dementia & Neuropsychologia · doi:10.1590/1980-57642018dn12-020003 · Cited by 102
Boda, E. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14621 · Cited by 80
Antidepression action of BDNF requires and is mimicked by Gαi1/3 expression in the hippocampus
Marshall, J. J., Zhou, X., Chen, G., Yang, S., Li, Y., Wang, Y., Zhang, Z.-Q., Jiang, Q., Birnbaumer, L., & Cao, C. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722493115 · Cited by 75
Cho, S.-Y., So, W.-Y., & Roh, H. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14050454 · Cited by 69
Yin, Y., Liu, J., Fan, Q.-C., Zhao, S., Wu, X., Wang, J., Liu, Y., Li, Y., & Lu, W. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02638-5 · Cited by 77
Methyldopa as an inductor of postpartum depression and maternal blues: A review
Wiciński, M., Malinowski, B., Puk, O., Socha, M. W., & Słupski, M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110196 · Cited by 64
Parsing the Network Mechanisms of Electroconvulsive Therapy
Leaver, A. M., Espinoza, R. T., Wade, B., & Narr, K. L. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.11.016 · Cited by 62
Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression
Boiko, D. I., Shkodina, A. D., Hasan, M. M., Bardhan, M., Kazmi, S. K., Chopra, H., Bhutra, P., Baig, A. A., & Skrypnikov, A. M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03646-5 · Cited by 66
Machado, M. O., Oriolo, G., Bortolato, B., Köhler, C. A., Maes, M. H. J., Solmi, M., Grande, I., Martín‐Santos, R., Vieta, E., & Carvalho, A. F. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.11.039 · Cited by 60
Self-citationThe Non-Survival Effects of Glial Cell Line-Derived Neurotrophic Factor on Neural Cells
Cortés, D., Carballo-Molina, O. A., Castellanos‐Montiel, M. J., & Velasco, I. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00258 · Cited by 58
Zeng, J., Ji, Y., Luan, F., Hu, J., Rui, Y., Liu, Y., Rao, Z., Liu, R., & Zeng, N. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115005 · Cited by 56
Brunoni, A. R., Padberg, F., Vieira, É. L. M., Teixeira, A. L., Carvalho, A. F., Lotufo, P. A., Gattaz, W. F., & Benseñor, I. M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.06.003 · Cited by 59
Self-citationBarahona-Fuentes, G. D. F., Ojeda, Á. H., & Ríos, L. J. C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18189477 · Cited by 55
Wang, L., Li, X., Chen, X., Qin, X., Kardami, E., & Cheng, Y. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00377 · Cited by 50
Yu, J.-Z., Wang, J. P., Sheridan, S. D., Perlis, R. H., & Rasenick, M. M. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0786-5 · Cited by 51
Peng, G., Yang, L., Wu, C., Zhang, L. L., Wu, C. Y., Fan, L., Shi, H. W., Hou, J., Zhang, L. M., Ma, X., et al. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104926 · Cited by 50
Deyama, S., & Kaneda, K. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109335 · Cited by 46
Sild, M., Ruthazer, E. S., & Booij, L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.09.014 · Cited by 47
Cheon, Y., Lee, S., Kim, M., Kim, H. O., Suh, Y. S., Ki‐Soo, P., Kim, R. B., Yang, H.-S., Kim, J., Son, C., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.05.012 · Cited by 50
Levada, O. A., & Troyan, A. S. (2017) · Annals of General Psychiatry · doi:10.1186/s12991-017-0161-3 · Cited by 49
Anhedonia as a clinical correlate of inflammation in adolescents across psychiatric conditions
Freed, R. D., Mehra, L. M., Laor, D., Patel, M., Alonso, C. M., Kim‐Schulze, S., & Gabbay, V. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1482000 · Cited by 42
Maffioletti, E., Silva, R. C., Bortolomasi, M., Baune, B. T., Gennarelli, M., & Minelli, A. (2021) · Brain Sciences · doi:10.3390/brainsci11091120 · Cited by 44
Wu, Y., Sun, D., Wang, B., Li, Y., & Ma, Y. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318764158 · Cited by 41
The Vessels Shaping Mental Health or Illness
Baruah, J., & Vasudevan, A. (2019) · The Open Neurology Journal · doi:10.2174/1874205x01913010001 · Cited by 39
Becerril‐Villanueva, E., Pérez‐Sánchez, G., Álvarez-Herrera, S., Girón‐Pérez, M. I., Arreola, R., Cruz-Fuentes, C. S., Palacios, L., de la Peña, F. R., & Pavón, L. (2019) · Mediators of Inflammation · doi:10.1155/2019/9130868 · Cited by 40
Roh, H., Cho, S.-Y., & So, W.-Y. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15040757 · Cited by 42
Daytime melatonin levels in saliva are associated with inflammatory markers and anxiety disorders
Sundberg, I., Rasmusson, A. J., Ramklint, M., Just, D., Ekselius, L., & Cunningham, J. L. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104514 · Cited by 38
Liu, X., Li, P., Ma, X., Zhang, J., Sun, X., Luo, X., & Zhang, Y. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.041 · Cited by 34
Walss‐Bass, C., Suchting, R., Olvera, R. L., & Williamson, D. E. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.03.006 · Cited by 35
Isung, J., Granqvist, M., Trepci, A., Huang, J., Schwieler, L., Kierkegaard, M., Erhardt, S., Jokinen, J., & Piehl, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-81306-4 · Cited by 33
Transcriptomic decoding of regional cortical vulnerability to major depressive disorder
Zhu, J., Chen, X., Lu, B., Li, X.-Y., Wang, Z., Cao, L., Chen, G., Chen, J.-S., Chen, T., Chen, T.-L., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06665-w · Cited by 35
Repeated arctigenin treatment produces antidepressant- and anxiolytic-like effects in mice
Du, Y., Li, W., Li, Y., Yang, J., Wang, X., Yin, S., Wang, X., de-la-Paz, O. I. V., Gao, Y., Chen, H., et al. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.12.005 · Cited by 31
Zhang, Q., Zhao, W., Yun, Y., Ma, T., An, H., Fan, N., Wang, J., Wang, Z., & Yang, F. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.12.070 · Cited by 32
Carboni, L., Marchetti, L., Lauria, M., Gass, P., Vollmayr, B., Redfern, A. J., Jones, L., Razzoli, M., Malki, K., Begni, V., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0117-6 · Cited by 30
Islam, S., Islam, T., Nahar, Z., Shahriar, M., Islam, S. M. A., Bhuiyan, M. A., & Islam, M. R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276619 · Cited by 31
Zhang, Y., Jiang, H., Yue, Y., Yin, Y., Zhang, Y., Liang, J., Li, S., Wang, J., Lü, J., Geng, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09000-y · Cited by 29
The Role of Neurotrophic Factors in Pathophysiology of Major Depressive Disorder
Amidfar, M., Réus, G. Z., de Moura, A. B., Quevedo, J., & Kim, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_14 · Cited by 31
Self-citationSchamne, M. G., Mack, J. M., Moretti, M., MATHEUS, F. C., Walz, R., Lanfumey, L., & Prediger, R. D. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9912-4 · Cited by 28
Han, D. K., Zhao, Z., Mao, T., Gao, M., Yang, X., & Gao, Y. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70150 · Cited by 30
Sun, B., Jia, X., Yang, F., Ren, G., & Wu, X. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.05.003 · Cited by 26
Lisitsyna, T. A., Veltishchev, D. Y., Lila, A. M., & Nasonov, E. L. (2019) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2019-318-327 · Cited by 26
Kranaster, L., Blennow, K., Zetterberg, H., & Sartorius, A. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.080 · Cited by 27
Neurotrophic and inflammatory markers in bipolar disorder: A prospective study
van den Ameele, S., Coppens, V., Schuermans, J., Boer, P. D., Timmers, M., Fransén, E., Sabbe, B., & Morrens, M. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.07.003 · Cited by 25
Hisaoka‐Nakashima, K., Taki, S., Watanabe, S., Nakamura, Y., Nakata, Y., & Morioka, N. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172539 · Cited by 24
Maffioletti, E., Gennarelli, M., Magri, C., Bocchio‐Chiavetto, L., Bortolomasi, M., Bonvicini, C., Abate, M., Trabucchi, L., Ulivi, S., & Minelli, A. (2020) · Drug Development Research · doi:10.1002/ddr.21658 · Cited by 25
Zhou, X., Shi, D., & Zhang, Z. (2018) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.08.001 · Cited by 24
Growth factors and neurotrophins in patients with stress-related exhaustion disorder
Sjörs, A., Blennow, K., Zetterberg, H., Glise, K., & Jónsdóttir, I. H. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104415 · Cited by 25
Castillo, M. F. R., Cohen, A. J., Edberg, D., Hoppensteadt, D., Fareed, J., Martin, B., & Halaris, A. E. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112781 · Cited by 23
Yurteri, N., Şahin, İ. E., & Tufan, A. E. (2019) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2019.1625437 · Cited by 23
Levada, O. A., Troyan, A. S., & Пінчук, І. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02636-7 · Cited by 23
Troyan, A. S., & Levada, O. A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00800 · Cited by 24
Sun, J., Kong, L., Wu, F., Wei, Y., Zhu, Y., Yin, Z., Deng, X., Jiang, X., Tang, Y., & Wang, F. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.068 · Cited by 22
Iacono, L. L., Bussone, S., Andolina, D., Tambelli, R., Troisi, A., & Carola, V. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.034 · Cited by 21
Black, R. D., & Rogers, L. L. (2020) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2020.00012 · Cited by 23
Vascular Endothelial Growth Factor (VEGF) in Neurodevelopmental Disorders
Howell, K. R., & Armstrong, J. (2017) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-017-0130-9 · Cited by 19
Fukuda, A. M., Hindley, L. E., Kang, J. W. D., Tirrell, E., Tyrka, A. R., Ayala, A., & Carpenter, L. L. (2020) · Neuroreport · doi:10.1097/wnr.0000000000001523 · Cited by 19
Xiao, W., Zhan, Q., Ye, F., Tang, X., Li, J., Dong, H., Sha, W., & Zhang, X. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.03.007 · Cited by 18
Sorri, A., Järventausta, K., Kampman, O., Lehtimäki, K. A., Björkqvist, M., Tuohimaa, K., Hämäläinen, M., Moilanen, E., & Leinonen, E. V. J. (2021) · Brain and Behavior · doi:10.1002/brb3.2001 · Cited by 15
Xiao, W., Ye, F., Ma, L., Tang, X., Li, J., Dong, H., Sha, W., & Zhang, X. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.11.001 · Cited by 17
Neurobiological Mechanisms of Electroconvulsive Therapy: Molecular Perspectives of Brain Stimulation
Fetahović, E., Janjic, V. S., Muric, M. D., Jovicic, N. U., Radmanović, B., Rosic, G. L., Selaković, D., Filipovic, M., & Muric, N. N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125905 · Cited by 16
Porcari, C., Cattaneo, S., Crippa, L., Simonato, M., & Bettegazzi, B. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1618330 · Cited by 16
Domaszewska, K., Koper, M., Wochna, K., Czerniak, U., Marciniak, K., Wilski, M., & Bukowska, D. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.586286 · Cited by 18
Causal relationship between diabetes and depression: A bidirectional Mendelian randomization study
Wang, Z., Du, Z., Lu, R., Zhou, Q., Jiang, Y., & Zhu, H. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.02.031 · Cited by 15
Nguyen, L., Kakeda, S., Katsuki, A., Sugimoto, K., Otsuka, Y., Ueda, I., Igata, R., Watanabe, K., Kishi, T., Iwata, N., et al. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0953-8 · Cited by 15
Li, X. Y., Wu, S. Y., & Leung, P. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174083 · Cited by 15
Li, K., Wang, K., Xu, S., Xie, X., Tang, Y., Zhang, L., & Liu, Z. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.09.073 · Cited by 14
Can Molecular Biology Propose Reliable Biomarkers for Diagnosing Major Depression?
Ivanets, N. N., Svistunov, A. А., Chubarev, V. N., Kinkulkina, M. A., Tikhonova, Y. G., Syzrantsev, N. S., Sologova, S. S., Ignatyeva, N. V., Mutig, K., & Tarasov, V. V. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201124110437 · Cited by 17
Peripheral blood E2F1 mRNA in depression and following electroconvulsive therapy
McGrory, C. L., Ryan, K. M., Kolshus, E., & McLoughlin, D. M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.10.011 · Cited by 13
Krivosova, M., Adamčáková, J., Kaadt, E., Mumm, B. H., Dvorská, D., Braný, D., Daňková, Z., Dohál, M., Samec, M., Ferencová, N., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.094 · Cited by 13
Wunram, H. L., Oberste, M., Ziemendorff, A., Hamacher, S., Kapanci, T., Heller, R., Blick, S., Bloch, W., Clajus, T. C., Schönaü, E., et al. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113596 · Cited by 14
Nerve Growth Factor in Psychiatric Disorders: A Scoping Review
Jaiswal, A., Shreekantiah, U., & Goyal, N. (2023) · Indian Journal of Psychological Medicine · doi:10.1177/02537176231162518 · Cited by 11
The Role of Neuropeptide Y mRNA Expression Level in Distinguishing Different Types of Depression
Yue, Y., Jiang, H., Yin, Y., Zhang, Y., Liang, J., Li, S., Wang, J., Lü, J., Geng, D., Wu, A., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00323 · Cited by 11
Liao, J., Mi, X., Zeng, G., Wei, Y., Dai, X., Ye, Q., Chen, X., & Zhang, J. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.086 · Cited by 9
Pittet, F., Caenegem, N. V., Hicks-Nelson, A., Junior, H. P. D. O. S., Bradburn, S., Murgatroyd, C., & Nephew, B. C. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12711 · Cited by 11
Liang, C., Wei, S., Ji, Y., Lin, J., Jiao, W., Li, Z., Yan, F., & Xi, J. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105931 · Cited by 13
Kenwood, M. M., Roseboom, P. H., Oler, J. A., & Kalin, N. H. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19030282 · Cited by 9
Bliźniewska-Kowalska, K. M., Gałecki, P., Szemraj, J., & Talarowska, M. E. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030168 · Cited by 8
Herrera, M. L., Basmadjian, O. M., Lockhart, E. F., Dolcetti, F. J. C., Hereñú, C. B., & Bellini, M. J. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112050 · Cited by 9
Mehra, A., Khanna, J., Singh, G., Sachdeva, V., & Bedi, N. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-025-00308-y · Cited by 8
Matsuzaka, Y., & Yashiro, R. (2025) · Biologics · doi:10.3390/biologics5010007 · Cited by 9
Adachi, S., Tokuda, N., Kobayashi, Y., Tanaka, H., Sawai, H., Shibahara, H., Takeshima, Y., Shima, M., & the Japan Environment and Children's Study Group (2021) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13200 · Cited by 8
Sun, S., Han, Y., Liu, X., Yang, L., Han, T., Lin, Y. H., & Feng, Y. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1480854 · Cited by 8
Xiong, Y. B., Guo, J., Yu, W., Zeng, D., Song, C., Zhou, L., Nadtochii, L. A., Baranenko, D., Xiao, D., Zhou, Y., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073094 · Cited by 8
Jia, F., Chen, X., Wang, X., Quan, C., Ruan, J., Huang, Y., Fu, X., Wang, Y., Sun, H., Liu, L., et al. (2025) · Psychoradiology · doi:10.1093/psyrad/kkaf014 · Cited by 7
Zhang, Y., Luan, D., Liu, Y., Li, H., Dong, J., Zhang, X., Yuan, L., Zhong, Z.-L., Jiang, L., Li, X., et al. (2020) · Chemistry & Biodiversity · doi:10.1002/cbdv.202000063 · Cited by 7
Kong, X.-M., Wang, J., Lv, S., Wang, C., Hong, H., Xie, P., Guo, Y., Zhu, N., Qin, P., Sun, Y., et al. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.340894 · Cited by 7
Tranquilizing and Allaying Excitement Needling Method Affects BDNF and SYP Expression in Hippocampus
Zheng, P., Xu, X., Zhao, H., Lv, T., Song, B., & Wang, F. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/8215949 · Cited by 7
Metadata
- Authors
- Sharma, A. N., da Costa e Silva, B. F. B., Soares, J. C., Carvalho, A. F., & Quevedo, J.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- ORCID
- Soares, Jair C.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 197
- Pages
- 9-20
- ISSN
- 0165-0327 (ISSN-L)
- PMC
- PMC4837031
- OpenAlex
- W2288312973
- Cited by
- 142
- References
- 74
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 9 · 2023: 10 · 2022: 11 · 2021: 16 · 2020: 18 · 2019: 17 · 2018: 21 · 2017: 17 · 2016: 5
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Affective Disorders (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R01MH085667)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- major depressive disorder, glial cell line-derived neurotrophic factor, insulin-like growth factor I, vascular endothelial growth factor, neurotrophins, neurogenesis, treatment response biomarkers, peripheral biomarkers, mRNA expression, antidepressant action, depression pathophysiology
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Female, Humans, Insulin-Like Growth Factor I, Male, Biomarkers, Vascular Endothelial Growth Factor A, Glial Cell Line-Derived Neurotrophic Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review